BENEFITS OF A PATIENT-ASSISTED MEDICATION ADHERENCE PROGRAM FOR LONG-ACTING INJECTABLE RISPERIDONE ON HIGH-COST OUTCOMES IN SCHIZOPHRENIA

被引：0
|
作者：
Astruc, B. [1 ]
Jalbert, J. J. [2 ]
Rouillon, F. [3 ]
Rossignol, M. [4 ]
Bayle, F. [5 ]
David, B. [6 ]
Bennoune, R. [6 ]
Avouac, B. [7 ]
Abenhaim, L. [8 ]
Grimaldi-Bensouda, L. [6 ]
机构：
[1] Eutelmed SAS, Fac Med Cochin Port Royal, Paris, France
[2] LA SER Analyt, New York, NY USA
[3] Ctr Hosp St Anne, Paris, France
[4] LA SER, Paris, France
[5] Univ Paris 05, Paris, France
[6] LA SER Res, Paris, France
[7] LA SER Analyt, Paris, France
[8] LA SER, London, England
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1231
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH12
引用
收藏
页码：A210 / A210
页数：1
相关论文
共 50 条
  • [1] Long-acting injectable risperidone for the treatment of schizophrenia
    Moeller, Hans-Juergen
    [J]. DRUGS, 2007, 67 (11) : 1541 - 1566
  • [2] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [3] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L
    Lam, A
    McCormick, J
    Luong, D
    Camacho, F
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A202 - A203
  • [4] Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
    Parellada, Eduard
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (02) : 82 - 100
  • [5] Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
    Kaplan, Gabriel
    Casoy, Julio
    Zummo, Jacqueline
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 1171 - 1180
  • [6] Neurocognition and attitudes to medication in risperidone long-acting injectable
    Penades, R.
    Catalan, R.
    Pujol, N.
    Navarro, V.
    Massana, G.
    Gasto, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S462 - S463
  • [7] Treatment adherence in schizophrenia using risperidone long-acting injectable: as early as possible, as long as possible
    Viala, A.
    Boulicot, V.
    Merlot, A.
    Pinede, D.
    Vacheron, M. N.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S516 - S517
  • [8] Benefits of compliance with long-acting risperidone in schizophrenia.
    Edwards, NC
    Rupnow, M
    Pashos, CL
    Diamond, RJ
    Botteman, MF
    [J]. PHARMACOTHERAPY, 2003, 23 (10): : 1360 - 1360
  • [9] Management of schizophrenia - Defining the role of long-acting injectable risperidone
    Curran, Monique P.
    Keating, Gillian M.
    [J]. DISEASE MANAGEMENT & HEALTH OUTCOMES, 2006, 14 (02) : 107 - 125
  • [10] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Kim, H.
    Hong, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S456
12345